Physician profile
Michael J Oneill
NPI 1215943808
$2,684.12
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $271 · 2021: $327 · 2022: $75.95 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,561.93 | 2019 | |
| Novo Nordisk INC | $241.50 | 2019-2022 | |
| Lilly USA, LLC | $121.81 | 2020-2024 | Mounjaro, Zepbound |
| Pfizer INC. | $114.60 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $105.43 | 2019-2021 | |
| Abbvie INC. | $98.08 | 2019-2022 | |
| Abiomed | $93.33 | 2024 | Impella |
| Sunovion Pharmaceuticals INC. | $54.69 | 2020-2021 | |
| Bausch Health US, LLC | $42.53 | 2020-2021 | |
| Gilead Sciences, INC. | $40.01 | 2021-2022 | |
| Cranial Technologies, INC | $31.04 | 2019-2021 | |
| Amgen INC. | $30.16 | 2019-2024 | Krystexxa |
| Teva Pharmaceuticals USA, INC. | $28.84 | 2019-2020 | |
| Eisai INC. | $28.17 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $19.46 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.21 | 2020 | |
| Medtronic, INC. | $15.72 | 2024 | Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $13.79 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.39 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.